Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Feb 23, 2016
Insider Transaction Report
Form 4
Logerfo Michael
Chief Legal Officer
Transactions
- Tax Payment
Common Stock
2016-02-22$14.61/sh−486$7,100→ 53,694 total - Tax Payment
Common Stock
2016-02-21$14.61/sh−744$10,870→ 54,180 total
Holdings
- 1,000(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]Shares held by a member of Mr. Logerfo's immediate family sharing the same household. Mr. Logerfo disclaims beneficial ownership of such shares.